Skip to content

Efficacy of subendometrial PRP injection for FET cycle of RIF patients

Evaluation of efficacy of subendometrial PRP injection for FET cycle of RIF patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091012002576N29
Enrollment
60
Registered
2023-08-10
Start date
2023-09-06
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. N97.8

Interventions

Intervention 1: "Intervention group": At the time of hysteroscopy in luteal phase under anesthesia, RPP that will be prepared before surgery, injected in subendometrial area of endometrial cavity at f

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: RIF patients Have good quality embryo Having signed informed consent Age 20-40 years

Exclusion criteria

Exclusion criteria: Severe male infertility BMI>30 Uncontrolled hypothyroidism User of corticosteroids User of glucose control agents CNS tumour Uterine malformation Cavity distorting lesions Severe endometriosis Liver disease Asherman syndrome

Design outcomes

Primary

MeasureTime frame
Endometrial thickness. Timepoint: At the day of start progesterone. Method of measurement: Transvaginal sonogram.;Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Bhcg titer.

Secondary

MeasureTime frame
Clinical pregnancy. Timepoint: Cardiac activity four weeks after embryo transfer. Method of measurement: Transvaginal sonogram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026